BiotechTube
ChoiceSpine

ChoiceSpine

Knoxville, United States· Est.
choicespine.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ChoiceSpine is a commercial-stage spinal implant manufacturer with a comprehensive portfolio of cervical, lumbar, and sacroiliac joint fusion systems. A key differentiator is its proprietary BioBond® 3D-printed porous titanium technology, designed to promote bone ingrowth and fusion. The company, founded in 2008 and now under the common ownership of Zavation Medical Products, emphasizes a surgeon-centric model and streamlined instrumentation to improve surgical efficiency. It operates in the competitive $10B+ global spinal device market, targeting growth through product innovation and surgeon partnerships.

Spinal DisordersDegenerative Disc DiseaseSacroiliac Joint Dysfunction

Technology Platform

Proprietary BioBond® 3D-printed porous titanium trabecular structure designed for bone ingrowth and fusion; integrated surgical instrumentation focused on efficiency and ease-of-use.

Opportunities

The growing adoption of minimally invasive spinal surgery and 3D-printed, porous implants presents a significant opportunity for ChoiceSpine's specialized portfolio.
Expansion of its BioBond® technology into new applications and leveraging the commercial scale of its parent company, Zavation, could drive market share growth.

Risk Factors

ChoiceSpine faces intense competition from large, established medtech firms with greater resources.
The company is also exposed to regulatory hurdles, pricing pressure from healthcare cost containment, and the risk that surgeons may be slow to adopt its newer technologies over familiar alternatives.

Competitive Landscape

ChoiceSpine competes in the highly consolidated spinal device market against giants like Medtronic, Stryker, and Johnson & Johnson, as well as larger spine-specialized firms like NuVasive and Globus Medical. Its differentiation relies on proprietary porous metal technology, surgeon collaboration, and streamlined instrumentation rather than scale.

More companies in Drug Delivery & Formulation →More companies in United States →